Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tasoula Touloumenidou

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Haematologica|July 14, 2011
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patientsEleni Arvaniti, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
Bioinformatics (Oxford, England)|October 17, 2017
GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace dataKarol Pal, Vojtech Bystry, Tomas Reigl, et al.
Thrombosis and Haemostasis|July 3, 2019
Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic MicroangiopathyEleni Gavriilaki, Akrivi Chrysanthopoulou, Ioanna Sakellari, et al.
Transplantation Proceedings|August 21, 2021
Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-DiseaseEleni Gavriilaki, Ioanna Sakellari, Thomas Chatzikonstantinou, et al.
Journal of Clinical Medicine|February 25, 2022
Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek CenterChristos Varelas, Eleni Gavriilaki, Ioanna Sakellari, et al.
International Journal of Molecular Sciences|November 25, 2023
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and OutcomesApostolia Papalexandri, Eleni Gavriilaki, Anna Vardi, et al.
Leukemia & Lymphoma|January 18, 2019
Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?Apostolia Papalexandri, Maria Karypidou, Evangelia Stalika, et al.
Journal of Personalized Medicine|April 27, 2024
Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled StudyTheodora-Maria Venou, Evangelia Vetsiou, Christos Varelas, et al.
International Journal of Molecular Sciences|July 29, 2025
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control StudyIoulia Mavrikou, Marta Castelli, Tasoula Touloumenidou, et al.
International Journal of Molecular Sciences|October 26, 2024
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell RecipientsEleni Gavriilaki, Christos Demosthenous, Paschalis Evangelidis, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Haematologica|July 14, 2011
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patientsEleni Arvaniti, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
Bioinformatics (Oxford, England)|October 17, 2017
GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace dataKarol Pal, Vojtech Bystry, Tomas Reigl, et al.
Thrombosis and Haemostasis|July 3, 2019
Linking Complement Activation, Coagulation, and Neutrophils in Transplant-Associated Thrombotic MicroangiopathyEleni Gavriilaki, Akrivi Chrysanthopoulou, Ioanna Sakellari, et al.
Transplantation Proceedings|August 21, 2021
Predictors of Transplant-Associated Thrombotic Microangiopathy in Patients With Overlap or Chronic Graft-vs-Host-DiseaseEleni Gavriilaki, Ioanna Sakellari, Thomas Chatzikonstantinou, et al.
Journal of Clinical Medicine|February 25, 2022
Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek CenterChristos Varelas, Eleni Gavriilaki, Ioanna Sakellari, et al.
International Journal of Molecular Sciences|November 25, 2023
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and OutcomesApostolia Papalexandri, Eleni Gavriilaki, Anna Vardi, et al.
Leukemia & Lymphoma|January 18, 2019
Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?Apostolia Papalexandri, Maria Karypidou, Evangelia Stalika, et al.
Journal of Personalized Medicine|April 27, 2024
Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled StudyTheodora-Maria Venou, Evangelia Vetsiou, Christos Varelas, et al.
International Journal of Molecular Sciences|July 29, 2025
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control StudyIoulia Mavrikou, Marta Castelli, Tasoula Touloumenidou, et al.
International Journal of Molecular Sciences|October 26, 2024
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell RecipientsEleni Gavriilaki, Christos Demosthenous, Paschalis Evangelidis, et al.
Pageof 2